Peter Blattmann
Peter Blattmann
Idorsia Pharmaceuticals Ltd
Verified email at idorsia.com
Title
Cited by
Cited by
Year
Entry of human papillomavirus type 16 by actin-dependent, clathrin-and lipid raft-independent endocytosis
M Schelhaas, B Shah, M Holzer, P Blattmann, L Kühling, PM Day, ...
PLoS Pathog 8 (4), e1002657, 2012
2542012
Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome
U Kusebauch, DS Campbell, EW Deutsch, CS Chu, DA Spicer, ...
Cell 166 (3), 766-778, 2016
2152016
Systems proteomics of liver mitochondria function
EG Williams, Y Wu, P Jha, S Dubuis, P Blattmann, CA Argmann, ...
Science 352 (6291), 2016
1902016
Characterization of drug‐induced transcriptional modules: towards drug repositioning and functional understanding
M Iskar, G Zeller, P Blattmann, M Campillos, M Kuhn, KH Kaminska, ...
Molecular systems biology 9 (1), 662, 2013
1062013
Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells
A Smed-Sörensen, C Chalouni, B Chatterjee, L Cohn, P Blattmann, ...
PLoS Pathog 8 (3), e1002572, 2012
872012
RNAi–based functional profiling of loci from blood lipid genome-wide association studies identifies genes with cholesterol-regulatory function
P Blattmann, C Schuberth, R Pepperkok, H Runz
PLoS Genet 9 (2), e1003338, 2013
502013
SWATH2stats: an R/bioconductor package to process and convert quantitative SWATH-MS proteomics data for downstream analysis tools
P Blattmann, M Heusel, R Aebersold
PloS one 11 (4), e0153160, 2016
322016
Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction
AS Thormaehlen, C Schuberth, HH Won, P Blattmann, ...
PLoS Genet 11 (2), e1004855, 2015
302015
Systematic characterization of pan‐cancer mutation clusters
M Buljan, P Blattmann, R Aebersold, M Boutros
Molecular Systems Biology 14 (3), e7974, 2018
232018
Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy
J Celis-Gutierrez, P Blattmann, Y Zhai, N Jarmuzynski, K Ruminski, ...
Cell Reports 27 (11), 3315-3330. e7, 2019
192019
Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS
T Sajic, Y Liu, E Arvaniti, S Surinova, EG Williams, R Schiess, ...
Cell Reports 23 (9), 2819-2831. e5, 2018
172018
Generation of a zebrafish SWATH-MS spectral library to quantify 10,000 proteins
P Blattmann, V Stutz, G Lizzo, J Richard, P Gut, R Aebersold
Scientific data 6, 190011, 2019
152019
High‐throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification
Y Zhu, T Weiss, Q Zhang, R Sun, B Wang, X Yi, Z Wu, H Gao, X Cai, ...
Molecular oncology 13 (11), 2305-2328, 2019
142019
Systems Pharmacology Dissection of Cholesterol Regulation Reveals Determinants of Large Pharmacodynamic Variability between Cell Lines
P Blattmann, D Henriques, M Zimmermann, F Frommelt, U Sauer, ...
Cell systems 5 (6), 604-619. e7, 2017
102017
PGC1α and exercise adaptations in zebrafish
A Parisi, P Blattmann, G Lizzo, V Stutz, L Strohm, J Richard, G Civiletto, ...
BioRxiv, 483784, 2018
42018
The Advent of Mass Spectrometry-Based Proteomics in Systems Biology Research
P Blattmann, R Aebersold
Encyclopedia of Cell Biology 4, 166-176, 2016
12016
Mass Spectrometric Exploration of the Biochemical Basis of Living Systems
R Aebersold, P Blattmann
CHIMIA International Journal for Chemistry 73 (7-8), 540-548, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–17